Investor Relations

Creating sustainable value for shareholders through innovation, strategic growth, and operational excellence.

The strategic business plan entails a roadmap of the company to expand its reach in the underserved regions, as well as the technology adoption of retail solutions like e-pharmacy and the capacity building of employees.

It also focuses on adhering to the Ghana Food and Drugs Authority (FDA) and the Pharmacy Council regulations to ensure credibility and safeguard the customers. The plan shows a 3-year growth trend of Nexto Pharmaceuticals Limited, where its retail facilities will expand, its wholesale relations with hospitals and clinics will improve, and its brand will be a trusted drug provider.

Nexto Pharmaceutical Company seeks debt financing in the amount of between $1,000,000 – $5,000,000 for a period of 5 years. Given its robust financial performance over the past three years, the company can generate cash flow to pay off the required loan amount within the stipulated 5-year period.

Investors Inquiry
  • Annual Reports and SEC Filings: Complete financial disclosures and regulatory filings
  • Quarterly Earnings Releases: Latest financial results and business updates
  • Investor Presentations: Strategic outlook and business segment performance
  • Stock Information: Real-time stock data and historical performance
  • Corporate Governance: Board committees, policies, and governance practices
  • Upcoming Events: Investor conferences, earnings calls, and annual meetings

For investor inquiries, please contact our Investor Relations team at investors@nextopharmaceuticals.com or call +233(0)244619246